Tag Archives: drugs

How Trump’s new drug proposal may impact older adults

Photo: Jen R via Flickr

Health and Human Services Secretary Alex Azar and Centers for Medicare & Medicaid Services Director Seems Verma are crisscrossing the country to tout the Trump administration’s plan to combat prescription drug prices. They promise that America’s Patients First, released by the president and HHS on May 11, will address significant roadblocks to lowering drug costs.

People age 65 and older account for 34 percent of all prescription medication use and 30 percent of all over-the-counter drugs purchased, according to this Medscape article. Azar, a former drug company executive, recently spoke with reporters and other stakeholders to promote the plan, saying that high prescription costs seriously threaten too many Americans’ health and wellbeing. Continue reading

These FDA apps can be helpful for reporting and story ideas

If you are familiar with  Drugs@FDA, you know that the website allows you to quickly look up a drug by its name (brand), the active ingredient (generic), or application number. But if you frequently work on the go or need to look up something quickly while away from your computer, you now can download the FDA’s new app, Drugs@FDA Express (iOS/Apple and Android/Google), to see much of the same information.

Released in late March, the app is pretty basic, but often that’s the best kind of app. It loads quickly, isn’t overly cluttered and has simpler user-friendly interface. The opening page is straightforward. Continue reading

Azar talks about plan to lower prescription drug prices

Alex Azar

Last week, President Trump spoke about his plans to lower prescription drug prices by increasing competition and creating incentives for them to lower prices.

His plan includes budget proposals to reform the Medicare Part D program, curbing abuse of FDA safety rules and  continuing generic drug approvals,
Continue reading

Do you have all the evidence on a drug that you’re reporting about?

Photo: Esther Dyson via Flickr

The registration and reporting requirements of Clinicaltrials.gov are vital to informing the evidence base – but only if study sponsors actually use it and keep entries updated. A recent research letter in JAMA Internal Medicine suggests this is not happening often enough. That’s helpful for journalists to know if they are attempting to find all the recent evidence on a particular drug or intervention.

“Missing or incomplete reporting of clinical trial results and its scientific and ethical consequences are well documented,” wrote Kevin M. Fain, J.D., M.P.H., Dr.PH, and his team at the National Institutes of Health.

Continue reading

Opioids the topic of daylong training for D.C. journalists

Photo: Ryan Basen Baltimore Health Commissioner Leana Wen, right, helps demonstrate how naloxone is administered.

Health journalists in Washington, D.C., participated in an all-day training session about reporting on the opioid crisis, hearing from treatment experts, medical providers and public health advocates.

The event took place Feb. 23 at the University of Maryland’s Philip Merrill College of Journalism, and was a partnership between the D.C. chapter of the Association of Health Care Journalists and the National Press Foundation. Continue reading